Lantern Pharma Inc. Common Stock (LTRN) is a publicly traded Healthcare sector company. As of July 8, 2026, LTRN trades at $3.18 with a market cap of $50.14M and a P/E ratio of -2.28. LTRN moved -9.80% today. Year to date, LTRN is +16.67%; over the trailing twelve months it is +13.33%. Its 52-week range spans $1.11 to $6.12. Analyst consensus is buy with an average price target of $25.00. Rallies surfaces LTRN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for LTRN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $3.18 |
| Market Cap | $50.14M |
| P/E Ratio | -2.28 |
| EPS | $-1.57 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.12 |
| 52-Week Low | $1.11 |
| Volume | 153.32K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-17.12M |
| Gross Margin | 0.00% |
1 analysts cover LTRN: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $25.00.